Research Article
Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment
Table 1
Characteristics of the study population.
| | Characteristics | DT group
CD4 counts <200 cells/mm3
() | ET group
CD4 counts 200–350 cells/mm3
() |
| | Median age in years (IQR) | 33 (18–48) | 36 (21–51) | | Female gender, number (%) | 32 (32) | 29 (22) | | Body mass index | 21.4 | 22.1 | | CD4, cells/mm3, median (IQR) | 132 (95.2–155.7) | 312 (271–324.2) | | CD8, cells/mm3, median (IQR) | 865 (774–1072) | 703 (655–747) | | CD4/CD8 ratio, median (IQR) | 0.14 (0.10–0.19) | 0.42 (0.35–0.55) | | CD3/HLA-DR (%) | 29 | 23 | | HIV RNA log10 | 4.54 (2.82–6.51) | 4.9 (2.91–6.9) | | Heterosexuals, (%) | 110 (79) | 67 (66) | | Injectable drug abuse, (%) | 15 (11) | 12 (12) | | Homosexual, (%) | 3 (2) | 1 (0.9) |
|
|
DT, delayed treatment; ET, early treatment; IQR, interquartile range.
|
